(Q41609798)

5 October 2017

Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide (English)

1 reference

5 October 2017

1 reference

S Abel

1

1 reference

5 October 2017

D J Nichols

series ordinal

2

1 reference

5 October 2017

C J Brearley

series ordinal

3

1 reference

5 October 2017

M D Eve

series ordinal

4

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

British Journal of Clinical Pharmacology

5 October 2017

1 reference

5 October 2017

49

1 reference

5 October 2017

64-71

1 reference

5 October 2017

1

1 reference

Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group

5 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Altered pharmacokinetics of oral flecainide by cimetidine.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Pharmacokinetic interactions of cimetidine 1987.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Effect of cimetidine and ranitidine on cardiovascular drugs

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Prediction of creatinine clearance from serum creatinine

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Pharmacodynamics and pharmacokinetics of the class III antiarrhythmic agent dofetilide (UK-68,798) in humans.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014890

Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization*

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00114.X

Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug

21 January 2018

1 reference

12 December 2020

Effects of the new class III antiarrhythmic drug dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris

1 reference

12 December 2020

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators

1 reference

12 December 2020

Cimetidine and procainamide secretion by proximal tubules in vitro

1 reference

12 December 2020

Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine

1 reference

12 December 2020

Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine

1 reference

12 December 2020

Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay

1 reference

12 December 2020

Liquid—liquid extraction and high-performance liquid chromatography for the determination of a novel antidysrhythmic agent (UK-68,798) in human urine

1 reference

12 December 2020

Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man

1 reference

12 December 2020

Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00114.X

Identifiers

DOI

1 reference

5 October 2017

1 reference

5 October 2017

1 reference